Azathioprine oral 50mg
Products billed under this code include Azasan, Azathioprine.
Payment limit per 50 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Azasan, Azathioprine.
Payment limit per 50 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Azasan | Bausch Health US, LLC | 65649-0231-41 | 150 | $15.45 |
| Azasan | Bausch Health US, LLC | 65649-0241-41 | 200 | $20.60 |
| Azathioprine | Amneal Pharmaceuticals, LLC | 60219-1076-01 | 100 | $10.30 |
| Azathioprine | Ascend Laboratories, LLC | 67877-0493-01 | 100 | $10.30 |
| Azathioprine | Ascend Laboratories, LLC | 67877-0493-05 | 500 | $51.50 |
| Azathioprine | American Health Packaging | 68084-0229-01 | 100 | $10.30 |
| Azathioprine | Glenmark Pharmaceuticals Inc., USA | 68462-0502-01 | 100 | $10.30 |
| Azathioprine | Bausch Health US, LLC | 68682-0231-01 | 150 | $15.45 |
| Azathioprine | Bausch Health US, LLC | 68682-0241-01 | 200 | $20.60 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.103 | −$0.033 | 50 MG | Azathioprine oral 50mg | v1, posted September 17, 2026 |
| 3Q26 | $0.136 | −$0.045 | 50 MG | Azathioprine oral 50mg | v1, posted September 15, 2026 |
| 2Q26 | $0.181 | +$0.124 | 50 MG | Azathioprine oral 50mg | v1, posted September 15, 2026 |
| 1Q26 | $0.057 | −$0.005 | 50 MG | Azathioprine oral 50mg | v1, posted September 15, 2026 |
| 4Q25 | $0.062 | −$2.079 | 50 MG | Azathioprine oral 50mg | v1, posted September 8, 2026 |
| 3Q25 | $2.141 | +$1.197 | 50 MG | Azathioprine oral 50mg | v1, posted March 10, 2026 |
| 2Q25 | $0.944 | −$0.321 | 50 MG | Azathioprine oral 50mg | v1, posted March 10, 2026 |
| 1Q25 | $1.265 | −$0.351 | 50 MG | Azathioprine oral 50mg | v1, posted December 19, 2025 |
| 4Q24 | $1.616 | −$0.217 | 50 MG | Azathioprine oral 50mg | v1, posted June 11, 2025 |
| 3Q24 | $1.833 | −$0.725 | 50 MG | Azathioprine oral 50mg | v1, posted June 11, 2025 |
| 2Q24 | $2.558 | −$2.001 | 50 MG | Azathioprine oral 50mg | v1, posted March 11, 2025 |
| 1Q24 | $4.559 | −$7.193 | 50 MG | Azathioprine oral 50mg | v1, posted December 19, 2024 |
| 4Q23 | $11.752 | −$1.949 | 50 MG | Azathioprine oral 50mg | v1, posted October 10, 2024 |
| 3Q23 | $13.701 | −$0.923 | 50 MG | Azathioprine oral 50mg | v1, posted June 5, 2024 |
| 2Q23 | $14.624 | +$2.779 | 50 MG | Azathioprine oral 50mg | v1, posted February 23, 2024 |
| 1Q23 | $11.845 | −$0.722 | 50 MG | Azathioprine oral 50mg | v1, posted December 6, 2023 |
| 4Q22 | $12.567 | +$3.422 | 50 MG | Azathioprine oral 50mg | v1, posted June 22, 2023 |
| 3Q22 | $9.145 | +$1.042 | 50 MG | Azathioprine oral 50mg | v1, posted June 9, 2023 |
| 2Q22 | $8.103 | +$0.396 | 50 MG | Azathioprine oral 50mg | v1, posted December 14, 2022 |
| 1Q22 | $7.707 | +$1.13 | 50 MG | Azathioprine oral 50mg | v1, posted June 8, 2022 |
| 4Q21 | $6.577 | +$2.866 | 50 MG | Azathioprine oral 50mg | v1, posted June 2, 2022 |
| 3Q21 | $3.711 | +$2.597 | 50 MG | Azathioprine oral 50mg | v1, posted June 2, 2022 |
| 2Q21 | $1.114 | +$0.13 | 50 MG | Azathioprine oral 50mg | v1, posted March 1, 2022 |
| 1Q21 | $0.984 | – | 50 MG | Azathioprine oral 50mg | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.